Differential impact of high‐dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma
Year: 2010
Type: article
Source: Cancer
DOI: 10.1002/cncr.25232
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1968656375
